Exact Sciences Stockholders Approve Acquisition by Abbott

The $105 per share deal is expected to close in Q2 2026.

Published on Feb. 20, 2026

Got story updates? Submit your updates here. ›

Exact Sciences Corporation, a leading provider of cancer screening and diagnostic tests, announced that its stockholders voted to approve the proposed acquisition of the company by Abbott. The transaction is expected to close before the end of the second calendar quarter of 2026, with Exact Sciences' stockholders receiving $105.00 in cash per share.

Why it matters

The acquisition of Exact Sciences by the healthcare giant Abbott will expand Abbott's cancer diagnostics portfolio and strengthen its position in the growing cancer screening and monitoring market. For Exact Sciences, the deal provides a significant return for shareholders and access to Abbott's resources to further develop its innovative cancer testing solutions.

The details

At the special meeting, preliminary results showed that more than 99% of the votes cast, representing approximately 67% of the total outstanding shares of Exact Sciences common stock, were voted in favor of the transaction. The deal is subject to the satisfaction or waiver of the remaining conditions to closing.

  • The special meeting of Exact Sciences stockholders was held on February 20, 2026.
  • The transaction is expected to close before the end of the second calendar quarter of 2026.

The players

Exact Sciences Corporation

A leading provider of cancer screening and diagnostic tests, helping patients and healthcare providers make timely, informed decisions before, during, and after a cancer diagnosis.

Abbott

A global healthcare company that provides a broad range of medical devices, diagnostic products, nutritional offerings, and branded generic pharmaceuticals.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee (Instagram)

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.